MMP2 - matrix metallopeptidase 2 Gene
Also Known as MMP-2
Species: Felis catus
Gene Type: protein coding
Gene ID: 101098838
MMP2 Products (1)
| mRNA | Protein | Name |
|---|---|---|
| XM_003998042.4 | XP_003998091.2 | 72 kDa type IV collagenase |
MMP2 Protein Structure
PG_binding_1
PG_binding_1: pfam01471 (70 - 97)
Peptidase_M10
Peptidase_M10: pfam00413 (118 - 446)
FN2
FN2: smart00059 (226 - 274)
FN2
FN2: smart00059 (284 - 332)
FN2
FN2: smart00059 (342 - 390)
HX
HX: cd00094 (466 - 660)
- 0
- 200
- 400
- 600
- 661 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
72 kDa type IV collagenase |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-B0493 | Niflumic acid | Inhibitor | 99.61% | Unkown |
| HY-B0689A | Indinavir sulfate | 99.97% | Yes | |
| HY-B0689 | Indinavir | 99.96% | Yes | |
| HY-B0493R | Niflumic acid (Standard) | Inhibitor | 99.93% | Unkown |
| HY-B0689B | Indinavir sulfate ethanolate | / | Unkown |
Clinical Phase
Bioactive Molecules
(10)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-12169 | Marimastat | Inhibitor | 99.81% | Phase 3 |
| HY-12170 | Prinomastat | 98.41% | Phase 3 | |
| HY-12170A | Prinomastat hydrochloride | 98.53% | Phase 3 | |
| HY-B0916 | Propoxur | 99.43% | Phase 3 | |
| HY-15768 | Ilomastat | Inhibitor | 99.14% | Phase 2 |
| HY-10398 | CTS-1027 | Inhibitor | 99.24% | Phase 2 |
| HY-106992 | S 3304 | Inhibitor | 99.75% | Phase 2 |
| HY-112160 | XL-784 free base | Inhibitor | / | Phase 2 |
| HY-160822 | AGG-523 | Inhibitor | 99.32% | Phase 1 |
| HY-114214 | CKD-712 | / | Phase 1 |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-P991419 | MSB-0254 | Inhibitor | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(148)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-N0431 | Astragaloside IV | Inhibitor | 99.93% | Unkown |
| HY-13564 | Batimastat | Inhibitor | 98.92% | Unkown |
| HY-12354 | SB-3CT | Inhibitor | 99.84% | Unkown |
| HY-122022 | JR-AB2-011 | Inhibitor | 98.15% | Unkown |
| HY-110397 | KP-457 | Inhibitor | 99.18% | Unkown |
| HY-W068119A | N-(2-Aminoethyl)maleimide hydrochloride | 99.97% | Unkown | |
| HY-122214 | AC-73 | Inducer | 99.91% | Unkown |
| HY-N0069 | Solamargine | 99.87% | Unkown | |
| HY-103444 | ARP-100 | Inhibitor | ≥99.0% | Unkown |
| HY-N0532 | Morroniside | Inhibitor | 99.94% | Unkown |
| HY-N2593 | Isorhapontigenin | 99.82% | Unkown | |
| HY-W591424 | m-PEG2000-NHS ester | Ligand | 95.89% | Unkown |
| HY-N0805 | Alisol B 23-acetate | 99.65% | Unkown | |
| HY-112546 | MMP-2 Inhibitor I | Inhibitor | 99.24% | Unkown |
| HY-N0853 | Alisol A | 99.59% | Unkown | |
| HY-107394 | UK 356618 | Inhibitor | 98.91% | Unkown |
| HY-124373 | ND-336 | Inhibitor | 97.16% | Unkown |
| HY-164159 | α-Glucosylrutin | Inhibitor | 96.32% | Unkown |
| HY-120149 | Inotodiol | 98.29% | Unkown | |
| HY-144707 | AK-778-XXMU | 99.96% | Unkown | |
| HY-N0249 | Saikosaponin C | Inducer | 98.09% | Unkown |
| HY-N0419 | Quercimeritrin | 99.48% | Unkown | |
| HY-146754 | MMP2-IN-1 | 99.24% | Unkown | |
| HY-113440 | 5-Methoxytryptophol | 99.95% | Unkown | |
| HY-128393 | Trilinolein | 98.0% | Unkown | |
| HY-124813 | PDZ1i | Inhibitor | 99.29% | Unkown |
| HY-162038 | RXP03 | Inhibitor | 98.82% | Unkown |
| HY-N0084 | Betulinaldehyde | Inhibitor | 98.72% | Unkown |
| HY-P3513 | β-Neo-Endorphin | Activator | 98.97% | Unkown |
| HY-N0566 | 23-Hydroxybetulinic acid | 99.44% | Unkown | |
| HY-107639 | UK-370106 | Inhibitor | ≥99.0% | Unkown |
| HY-116474 | Viridicatol | 99.93% | Unkown | |
| HY-N7627 | Regaloside C | 99.62% | Unkown | |
| HY-P2213 | GPLGIAGQ | Inducer | 99.74% | Unkown |
| HY-116399 | MMP-2/MMP-9-IN-1 | Inhibitor | 99.48% | Unkown |
| HY-12168 | Tanomastat | Inhibitor | 99.74% | Unkown |
| HY-107428 | PD-166793 | Inhibitor | 99.21% | Unkown |
| HY-117970 | MMPI-1154 | Inhibitor | 99.76% | Unkown |
| HY-122506 | Salviolone | Inhibitor | 99.32% | Unkown |
| HY-W001925 | 7-Methoxy-1-tetralone | 99.93% | Unkown | |
| HY-101535 | ARP101 | Inhibitor | ≥99.0% | Unkown |
| HY-110397G | KP-457 (GMP) | Inhibitor | / | Unkown |
| HY-120213 | YH-306 | 98.34% | Unkown | |
| HY-19485 | XL-784 | Inhibitor | 98.25% | Unkown |
| HY-W011085 | CP-471474 | Inhibitor | 99.2% | Unkown |
| HY-143657 | Myoferlin inhibitor 1 | Inhibitor | 99.88% | Unkown |
| HY-P2213A | GPLGIAGQ TFA | Inducer | 99.89% | Unkown |
| HY-148571 | TP0597850 | Inhibitor | 99.09% | Unkown |
| HY-114785 | BPHA | Inhibitor | 99.88% | Unkown |
| HY-126941 | Hecogenin acetate | 98.57% | Unkown | |
| HY-176184 | PROTAC DDR1 degrader-1 | 98.69% | Unkown | |
| HY-N5136 | 25(R,S)-Ruscogenin | Inhibitor | 99.83% | Unkown |
| HY-N6896 | Isoviolanthin | Inhibitor | 99.87% | Unkown |
| HY-P10143 | MMP-2/MMP-9 Substrate | Substrate | 98.48% | Unkown |
| HY-114911 | Feprazone | Inhibitor | 99.88% | Unkown |
| HY-119979 | Cardanol monoene | Inducer | 98.02% | Unkown |
| HY-147745 | MMP2-IN-2 | Inhibitor | 98.80% | Unkown |
| HY-181654 | Snail IN-1 | Inhibitor | 98.27% | Unkown |
| HY-N7385 | Nudol | 99.60% | Unkown | |
| HY-P0273A | Histatin 5 TFA | Inhibitor | 99.98% | Unkown |
| HY-13564A | Batimastat sodium salt | Inhibitor | 99.04% | Unkown |
| HY-N16129 | Diplacone | 98.38% | Unkown | |
| HY-110116 | SD-2590 hydrochloride | Inhibitor | 99.4% | Unkown |
| HY-120349 | LL-Z1640-4 | Inhibitor | 99.0% | Unkown |
| HY-130076 | MMP-2 Inhibitor II | Inhibitor | 98.0% | Unkown |
| HY-131417 | cis-ACCP | Inhibitor | 97.0% | Unkown |
| HY-147031 | JAMM protein inhibitor 2 | Inhibitor | 98.20% | Unkown |
| HY-147746 | MMP2-IN-3 | Inhibitor | 99.64% | Unkown |
| HY-P1789A | CTTHWGFTLC, CYCLIC TFA | Inhibitor | 98.52% | Unkown |
| HY-160187A | (Rac)-AAA | 99.02% | Unkown | |
| HY-RS08537 | MMP2 Human Pre-designed siRNA Set A | / | Unkown | |
| HY-77813S | Benzyl isothiocyanate-d7 | / | Unkown | |
| HY-105854 | Pipoxolan hydrochloride | / | Unkown | |
| HY-109747 | RO-28-2653 | Inhibitor | / | Unkown |
| HY-111172 | Inotilone | Inhibitor | 95.26% | Unkown |
| HY-113621B | Ageladine A dihydrochloride | Inhibitor | / | Unkown |
| HY-114396 | BR351 | Inhibitor | / | Unkown |
| HY-116474R | Viridicatol (Standard) | / | Unkown | |
| HY-119185 | AZD-6605 | / | Unkown | |
| HY-120339 | STK899704 | / | Unkown | |
| HY-12168B | (Rac)-Tanomastat | Inhibitor | / | Unkown |
| HY-124373A | (R)-ND-336 | Inhibitor | / | Unkown |
| HY-128393S2 | Trilinolein-d5 | / | Unkown | |
| HY-136699 | Excisanin A | Inhibitor | / | Unkown |
| HY-138195 | NEO212 | / | Unkown | |
| HY-14237 | SC-77964 | Inhibitor | / | Unkown |
| HY-143407 | FAK-IN-3 | Inhibitor | / | Unkown |
| HY-147867 | MMP-2/9-IN-1 | Inhibitor | / | Unkown |
| HY-147936 | TP0556351 | Inhibitor | / | Unkown |
| HY-149378 | MMP13-IN-5 | Inhibitor | / | Unkown |
| HY-152030 | Tubulin/MMP-IN-2 | / | Unkown | |
| HY-154698 | Homouridine | / | Unkown | |
| HY-155201 | YJ182 | Inhibitor | / | Unkown |
| HY-155721 | 22-(4′-py)-JA | Inhibitor | / | Unkown |
| HY-156247 | IVMT-Rx-3 | Inhibitor | / | Unkown |
| HY-15668 | ST09 | / | Unkown | |
| HY-157382 | AChE-IN-51 | Inhibitor | / | Unkown |
| HY-160720 | ASPH-IN-1 | Inhibitor | / | Unkown |
| HY-161707 | MMP2-IN-4 | Inhibitor | / | Unkown |
| HY-162344 | Ir-CA | Inducer | / | Unkown |
| HY-165386 | TU-100 | Inhibitor | / | Unkown |
| HY-168560 | MMP Inhibitor 4 | Inhibitor | / | Unkown |
| HY-168605 | DH-18 | / | Unkown | |
| HY-170604 | MMP-2 Inhibitor-4 | Inhibitor | / | Unkown |
| HY-171776 | OPB-3206 | Inhibitor | / | Unkown |
| HY-172088 | Tubulin/MMP-IN-3 | / | Unkown | |
| HY-172551 | anti-TNBC agent-9 | / | Unkown | |
| HY-175291 | Cystatin B agonist 1 | / | Unkown | |
| HY-175815 | Apoptosis inducer 44 | / | Unkown | |
| HY-176149 | Fluoxetine-Conjugated Platinum(IV) prodrug-1 | / | Unkown | |
| HY-180117 | MMP-2/9-IN-2 | / | Unkown | |
| HY-180765 | Colchicine-O-CO-Enyl(Me)-Enyl-Enyl(Me)-Enyl-1,3,3-trimethylcyclohex-1-ene | Activator | / | Unkown |
| HY-181272 | MMP-9-IN-14 | / | Unkown | |
| HY-182795 | Colchicine derivative-1 | / | Unkown | |
| HY-18694 | CGS 27023A | Inhibitor | / | Unkown |
| HY-18694A | CGS 27023A free base | Inhibitor | / | Unkown |
| HY-B0916R | Propoxur (Standard) | 99.04% | Unkown | |
| HY-B0916S | Propoxur-d3 | / | Unkown | |
| HY-N10176 | D-Isofloridoside | Inhibitor | 98.59% | Unkown |
| HY-N15588 | Smyrindiol | Inhibitor | / | Unkown |
| HY-N17617 | S-Petasin | / | Unkown | |
| HY-P11746 | GPLGIAGQC | / | Unkown | |
| HY-P1789 | CTTHWGFTLC, CYCLIC | Inhibitor | / | Unkown |
| HY-P3477 | Mca-PLA-Nva-Dap(Dnp)-AR-NH2 | / | Unkown | |
| HY-P3513A | β-Neo-Endorphin acetate | Activator | / | Unkown |
| HY-P3699 | TNO003 | Substrate | / | Unkown |
| HY-P4574 | VPLSLYSG | / | Unkown | |
| HY-P5764 | TRAP-14 amide | / | Unkown | |
| HY-RS08538 | Mmp2 Mouse Pre-designed siRNA Set A | / | Unkown | |
| HY-RS08539 | Mmp2 Rat Pre-designed siRNA Set A | / | Unkown | |
| HY-W012856 | 3-Ethyltoluene | / | Unkown | |
| HY-W095774 | (E)-N-(3-Methoxyphenyl)cinnamamide | Inhibitor | / | Unkown |
| HY-W277900 | 2-Methoxy-2,4-diphenylfuran-3-one | / | Unkown | |
| HY-W750153 | Propoxur-d7 | / | Unkown | |
| HY-105854A | Pipoxolan | / | Unkown | |
| HY-113440R | 5-Methoxytryptophol (Standard) | / | Unkown | |
| HY-119110 | LY52 | Inhibitor | / | Unkown |
| HY-123130 | ABT-770 | Inhibitor | / | Unkown |
| HY-124341 | ND-378 | Inhibitor | / | Unkown |
| HY-128393S1 | Trilinolein-13C54 | / | Unkown | |
| HY-133845 | CIL-102 | / | Unkown | |
| HY-164525 | SD-7300 | Inhibitor | / | Unkown |
| HY-35513 | 3-Aminobenzene-1,2-diol | Inhibitor | 98.0% | Unkown |
| HY-43586 | BR351 precursor | Inhibitor | / | Unkown |
| HY-B0689S1 | Indinavir-13C4,15N | / | Unkown | |
| HY-N13208 | Stevia Powder | / | Unkown | |
| HY-P3699A | TNO003 TFA | Substrate | / | Unkown |
| HY-P0273 | Histatin 5 | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P991609 | ABX-MA1 | Inhibitor | / | Unkown |